Global Information
회사소개 | 문의 | 비교리스트

세계의 유방병변 위치특정 시장(-2026년) : 유형별, 용도별, 최종 사용자, 선호 조사

Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL,RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy,Lumpectomy), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2026

리서치사 MarketsandMarkets
발행일 2022년 01월 상품코드 1046569
페이지 정보 영문 232 Pages 배송안내
가격
US $ 4,950 ₩ 6,307,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,473,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 10,384,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 12,742,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 유방병변 위치특정 시장(-2026년) : 유형별, 용도별, 최종 사용자, 선호 조사 Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL,RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy,Lumpectomy), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2026
발행일 : 2022년 01월 페이지 정보 : 영문 232 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 유방병변 위치특정 시장 규모는 2021년 2억 4,400만 달러에서 2026년 3억 500만 달러 규모로 성장할 것으로 예측됩니다.

이 시장의 성장은 주로 유방암 발생률의 증가, 노년 인구의 증가, 유방암의 조기 발견에 대한 의식의 증가 등 요인이 이 시장의 성장을 촉진하고 있습니다. 그러나 한편, 규제 당국에 의한 승인 절차의 불확실성 등 여러 요인이 예측 기간 동안 시장 성장을 억제할 것으로 예측되고 있습니다.

유형별로 볼 때 와이어 현지화 부문은 2020년 금액 기준으로 가장 큰 점유율을 보여줍니다. 이상 조직의 적절한 유치특정, 정상 조직의 최소한의 제거, 최소한의 흉터, 유방병변 유치특정 장치에 대한 상환 가능성 등이 이 부문의 성장을 촉진하는 주요 요인이 되고 있습니다. 또한 용도별로 유방생검 부문이 2020년에 가장 큰 점유율을 보여줍니다. 유방암 발생률의 증가, 유방암 검진 프로그램의 증가, 상환 시나리오의 개선, 유방암의 조기 발견에 대한 의식 증가, 저침습·비침습 수술에 대한 수요의 증가 등 요인이 이 부문의 성장을 견인하고 있다 합니다.

세계의 유방병변 위치특정(Breast Lesion Localization) 시장을 조사했으며, 시장 정의 및 개요/신종 코로나 바이러스 감염증(COVID-19) 및 기타 시장 영향 요인 분석/법규/상환 환경/기술 및 특허 분석/시장규모의 추이·예측/유형·용도·지역 및 주요국 등 각종 구분별 내역/경쟁 환경/주요 기업 개요 등을 정리했습니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

  • 시장역학
    • 시장 촉진 요인
    • 시장 억제 요인
    • 시장 기회
    • 과제

제6장 산업 고찰

  • 산업 동향
  • COVID-19의 영향
  • 밸류체인 분석
  • 상환 분석
  • 기술분석
  • 포터의 5세력 모형 분석
  • 규제 분석
  • 특허 분석

제7장 유방병변 위치특정 시장 : 유형별

  • COVID-19의 영향
  • 와이어 위치특정
  • 방사성동위원소 위치특정
    • ROLL
    • RSL
  • 자기 위치특정
  • 전자기 위치특정
  • 기타

제8장 유방병변 위치특정 시장: 용도별

  • 유방 생검
  • 유방 온존(유선 부분 절제)

제9장 유방병변 위치특정 시장 : 지역별

  • 북미
  • 유럽
  • 아시아 태평양
  • 기타 지역

제10장 경쟁 상황

  • 개요
  • 주요 기업의 전략
  • 주요 기업의 수익 점유율 분석
  • 시장 점유율 분석
  • 기업 평가 쿼드런트
  • 신흥 기업의 기업 평가 쿼드런트
  • 기업의 제품 발자국
  • 주요 기업의 지리적 발자국
  • 경쟁 시나리오
  • 비교 분석
  • 선정 기준의 평가
  • 재건 동향의 정성 평가

제11장 기업 개요

  • 주요 기업
    • HOLOGIC, INC.
    • BECTON, DICKINSON AND COMPANY
    • MERIT MEDICAL SYSTEMS
    • LEICA BIOSYSTEMS NUSSLOCH GMBH
    • ARGON MEDICAL DEVICES
    • LAURANE MEDICAL LLC
    • ENDOMAGNETICS LTD.(ENDOMAG)
    • INTRAMEDICAL IMAGING, LLC
    • ISOAID
    • SURGICEYE GMBH
  • 기타 기업
    • RANFAC CORP.
    • MERMAID MEDICAL GROUP
    • IZI MEDICALPRODUCTS, LLC
    • MATEK MEDIKAL
    • TSUNAMI MEDICAL SRL
    • BPB MEDICA
    • SIRIUS MEDICAL SYSTEMS BV
    • MOLLI SURGICAL INC.
    • STERYLAB SRL
    • CP MEDICAL
    • MDL SRL
    • BIOMEDICAL SRL
    • ELUCENT MEDICAL
    • VIGEO SRL
    • MEDAX MEDICAL DEVICES

제12장 부록

LYJ 22.01.28

The breast lesion localization market is expected to reach USD 305 million by 2026 from USD 244 million in 2021. The growth of this market is mainly attributed to the growing incidence of breast cancer, the increasing rate of the geriatric population (as age contributes to the risk of breast cancer and the rising awareness on the early detection of breast cancer in the coming years. However, several factors, such as uncertainty in regulatory approval procedures, are expected to restrain the growth of the breast lesion localization market during the forecast period.

In this report, the breast lesion localization market is segmented based on type, usage, and region.

In terms of value, the wire localization segment accounted for the largest share of the breast lesion localization market in 2020

Based on type, the breast lesion localization market is segmented into wire localization, radioisotope localization, magnetic localization, electromagnetic localization, and other localization methods. In terms of value, the wire localization segment accounted for the largest share of the breast lesion localization market in 2020. The appropriate localization of abnormal tissues, the minimum removal of normal tissues, minimum scarring, and the availability of reimbursement for breast lesion localization devices are the major factors driving the growth of the wire localization segment.

Radio-guided occult lesion localization (ROLL) segment accounted for the largest share of the radioisotope localization market in 2020

Radioisotope localization is used for preoperative nonpalpable lesion localization during breast cancer surgeries as well as for sentinel lymph node mapping in cancer staging. By type, the radioisotope localization methods market is segmented into radio-guided occult lesion localization (ROLL) and radioactive seed localization (RSL). ROLL segment accounted for the largest share of the breast lesion localization market in 2020.

In 2020, the breast biopsy segment accounted for the largest share of the breast lesion localization market.

Based on usage, the breast lesion localization methods market is segmented into Breast Biopsy and Breast Conservation (Lumpectomy). In 2020, the breast biopsy segment accounted for the largest share of the breast lesion localization market. The factors driving the growth of the market are the growing incidence of breast cancer, the rising number of breast cancer screening programs, improved reimbursement scenarios, increased awareness of early detection of breast cancer, and greater demand for minimally invasive and non-invasive procedures.

North America accounted for the largest share of the breast lesion localization market in 2020

The breast lesion localization market is segmented into four major regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (RoW).

In terms of value, North America accounted for the largest share of the breast lesion localization market is 2020, followed by Europe. The APAC market is projected to grow at the highest CAGR during the forecast period. Growth in this market can primarily be attributed to the rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure, rising government spending on breast cancer research, and increasing awareness about the importance of the early detection of breast cancer in several APAC countries.

In-depth interviews have been conducted with chief executive officers (CEOs), marketing managers, and other executives from various key organizations operating in the automotive sensors marketplace.

  • By Company Type: Tier 1 - 55%, Tier 2 - 30%, and Tier 3 - 15%
  • By Designation: C-level Executives - 28%, Managers - 33%, and Others - 39%
  • By Region: Europe - 20%, Asia Pacific - 30%, North America - 35%, and RoW - 15%

Key players in the breast lesion localization market

The prominent players in the breast lesion localization market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US), Laurane Medical LLC (France), Endomagnetics Ltd. (UK), Intramedical Imaging, LLC (US), Isoaid (US), Surgiceye GmbH (Germany), Ranfac Corp. (US), Mermaid Medical Group (Denmark), Izi Medical Products, LLC (US), Matek Medikal (Turkey), Tsunami Medical Srl (Italy), BPB Medica (Italy), Sirius Medical Systems B.V. (Netherlands), Molli Surgical Inc. (Canada). Other players in the breast lesion localization market are Sterylab S.R.L. (Italy), CP Medical (Georgia), MDL SRL (Italy), Biomedical Srl (Italy), Elucent Medical (US), Vigeo srl (Italy), and Medax Medical Devices (Italy).

Research Coverage:

The report analyzes the breast lesion localization market and aims at estimating the market size and future growth potential of this market based on various segments such as type, usage, and region. The report also includes a product portfolio matrix of various breast lesion localization products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global breast lesion localization market. The report analyzes this market by type, usage, and region
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global breast lesion localization market
  • Market Development: Comprehensive information on the lucrative emerging markets by type, usage and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global breast lesion localization market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global breast lesion localization market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.4 SCOPE OF THE STUDY
    • 1.4.1 MARKETS COVERED
    • FIGURE 1 GLOBAL BREAST LESION LOCALIZATION MARKET
    • 1.4.2 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 6 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION:
    • FIGURE 8 REVENUE ANALYSIS OF THE TOP FOUR COMPANIES: BREAST LESION LOCALIZATION MARKET (2020)
    • FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE BREAST LESION LOCALIZATION MARKET (2021-2026)
    • FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
    • FIGURE 11 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: BREAST LESION LOCALIZATION MARKET
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 13 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (THOUSAND PROCEDURES)
    • FIGURE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (THOUSAND PROCEDURES)
    • FIGURE 16 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021 VS. 2026 (THOUSAND PROCEDURES)
    • FIGURE 18 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 19 GEOGRAPHIC ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (BASED ON PROCEDURE)
    • FIGURE 20 GEOGRAPHIC ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (BASED ON VALUE)

4 PREMIUM INSIGHTS

  • 4.1 BREAST LESION LOCALIZATION MARKET OVERVIEW
    • FIGURE 21 RISING AWARENESS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE
    • FIGURE 22 WIRE LOCALIZATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC BREAST LESION LOCALIZATION MARKET IN 2020
  • 4.3 BREAST LESION LOCALIZATION MARKET (BASED ON VALUE): GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 23 APAC COUNTRIES TO WITNESS THE HIGHEST GROWTH IN THE BREAST LESION LOCALIZATION MARKET DURING THE FORECAST PERIOD
  • 4.4 BREAST LESION LOCALIZATION MARKET, BY REGION
    • FIGURE 24 NORTH AMERICA TO DOMINATE THE BREAST LESION LOCALIZATION MARKET TILL 2026
  • 4.5 BREAST LESION LOCALIZATION MARKET: DEVELOPED VS. DEVELOPING MARKETS (THOUSAND PROCEDURES)
    • FIGURE 25 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • FIGURE 26 BREAST LESION LOCALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.1.1 MARKET DRIVERS
      • 5.1.1.1 Increasing incidence of breast cancer
    • TABLE 2 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF BREAST CANCER, 2020
    • FIGURE 27 ESTIMATED GLOBAL NUMBER OF NEW CASES OF BREAST CANCER FROM 2020-2040
      • 5.1.1.2 Growing rate of the aging population
      • 5.1.1.3 Increasing awareness on the early detection of breast cancer
    • 5.1.2 MARKET RESTRAINTS
      • 5.1.2.1 Uncertainty in regulatory approval procedures
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 Emerging economies offer high growth potential
      • 5.1.3.2 Increasing adoption of technologically advanced localization procedures
    • 5.1.4 CHALLENGES
      • 5.1.4.1 Shortage of oncologists

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 ELECTROMAGNETIC WAVES FOR THE LOCALIZATION OF BREAST LESIONS
    • 6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION
    • 6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION
  • 6.2 IMPACT OF COVID-19 ON THE BREAST LESION LOCALIZATION MARKET: RESTRUCTURING OF BREAST CANCER CARE
  • 6.3 VALUE CHAIN ANALYSIS
  • 6.4 REIMBURSEMENT ANALYSIS
    • TABLE 3 MEDICARE REIMBURSEMENT FOR BREAST LESION LOCALIZATION METHODS
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGIES
      • 6.5.1.1 Wire guided localization (WL)
      • 6.5.1.2 Carbon making
      • 6.5.1.3 Radio-guided occult lesion localization (ROLL)
      • 6.5.1.4 Radioactive seed localization (RSL)
      • 6.5.1.5 Magnetic seed localization (MSL)
      • 6.5.1.6 Radio frequency reflector (RFR)
    • 6.5.2 COMPLEMENTARY TECHNOLOGIES
      • 6.5.2.1 Mammography
      • 6.5.2.2 3D Mammography or Tomosynthesis
      • 6.5.2.3 Magnetic resonance imaging
      • 6.5.2.4 Ultrasound
    • 6.5.3 ADJACENT TECHNOLOGIES
      • 6.5.3.1 Computer vision and artificial intelligence
  • 6.6 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 BREAST LESION LOCALIZATION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.6.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.6.2 BARGAINING POWER OF SUPPLIERS
    • 6.6.3 BARGAINING POWER OF BUYERS
    • 6.6.4 THREAT OF SUBSTITUTES
    • 6.6.5 THREAT OF NEW ENTRANTS
  • 6.7 REGULATORY ANALYSIS
    • 6.7.1 NORTH AMERICA
      • 6.7.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 6.7.1.2 Canada
    • TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • TABLE 8 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA
    • 6.7.2 EUROPE
    • FIGURE 28 EUROPE: CLASS III MEDICAL DEVICES
    • 6.7.3 ASIA PACIFIC
      • 6.7.3.1 India
  • 6.8 PATENT ANALYSIS
    • 6.8.1 PATENT PUBLICATION TRENDS FOR BREAST LESIONS
    • FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2011-DECEMBER 2021)
    • 6.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BREAST LESION PATENTS (JANUARY 2011-DECEMBER 2021)
    • FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR BREAST LESION PATENTS (JANUARY 2011-DECEMBER 2021)

7 BREAST LESION LOCALIZATION MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 9 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 10 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 7.2 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION MARKET, BY TYPE
  • 7.3 WIRE LOCALIZATION
    • 7.3.1 WIRE LOCALIZATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE BREAST LESION LOCALIZATION MARKET
    • TABLE 11 WIRE LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 12 WIRE LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.4 RADIOISOTOPE LOCALIZATION
    • TABLE 13 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 14 RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 15 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 16 RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.1 RADIOGUIDED OCCULT LESION LOCALIZATION (ROLL)
      • 7.4.1.1 ROLL to result in shorter operating times, higher rates of tumor-free margins, and lower rates of re-operation
    • TABLE 17 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 18 RADIOGUIDED OCCULT LESION LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • 7.4.2 RADIOACTIVE SEED LOCALIZATION (RSL)
      • 7.4.2.1 Reduction in re-excision rates, decreased operative time, and long half-life of RSL to drive market growth
    • TABLE 19 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 20 RADIOACTIVE SEED LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.5 MAGNETIC LOCALIZATION
    • 7.5.1 MAGNETIC LOCALIZATION TECHNIQUE TO INCREASE WORKFLOW EFFICIENCY AND COST-EFFECTIVENESS, ELIMINATE ISSUES RELATED TO NONRADIOACTIVE TECHNOLOGY, AND IMPROVE SURGICAL PLANNING
    • TABLE 21 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 22 MAGNETIC LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.6 ELECTROMAGNETIC LOCALIZATION
    • 7.6.1 ELECTROMAGNETIC LOCALIZATION TO MAKE SMALLER INCISIONS TO BE MORE PRECISE AND SAVE MORE OF THE NORMAL TISSUE DURING SURGERIES
    • TABLE 23 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 24 ELECTROMAGNETIC LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
  • 7.7 OTHER LOCALIZATION METHODS
    • TABLE 25 OTHER LOCALIZATION METHODS MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 26 OTHER LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)

8 BREAST LESION LOCALIZATION MARKET, BY USAGE

  • 8.1 INTRODUCTION
    • TABLE 27 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 28 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
  • 8.2 BREAST BIOPSY
    • 8.2.1 BREAST BIOPSY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE BREAST LESION LOCALIZATION MARKET BY USAGE
    • TABLE 29 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 30 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2019-2026 (USD MILLION)
  • 8.3 BREAST CONSERVATION (LUMPECTOMY)
    • 8.3.1 INCREASING ADOPTION OF BREAST CONSERVATION THERAPY TO DRIVE THE GROWTH OF BREAST LESION LOCALIZATION MARKET
    • TABLE 31 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 32 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2019-2026 (USD MILLION)

9 BREAST LESION LOCALIZATION MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 32 NUMBER OF BREAST CANCER CASES VS NUMBER OF DEATHS IN 2020 (IN THOUSANDS)
    • TABLE 33 BREAST LESION LOCALIZATION MARKET, BY REGION, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 34 BREAST LESION LOCALIZATION MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 33 NORTH AMERICA: NUMBER OF BREAST CANCER CASES 2020 (IN THOUSANDS)
    • TABLE 35 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 36 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 37 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 38 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 39 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 40 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 42 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.2.1 US
    • TABLE 43 US: KEY MACROINDICATORS
    • TABLE 44 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 45 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 46 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 47 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 48 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 49 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
    • TABLE 50 CANADA: KEY MACROINDICATORS
    • TABLE 51 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 52 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 53 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 54 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 55 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 56 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • FIGURE 35 EUROPE: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS)
    • TABLE 57 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 58 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 59 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 60 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 62 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 63 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 64 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
    • TABLE 65 GERMANY: KEY MACROINDICATORS
    • TABLE 66 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 67 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 GERMANY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 69 GERMANY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 70 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 71 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
    • TABLE 72 FRANCE: KEY MACROINDICATORS
    • TABLE 73 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 74 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 FRANCE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 76 FRANCE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 78 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.3 UK
    • TABLE 79 UK: KEY MACROINDICATORS
    • TABLE 80 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 81 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 82 UK: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 83 UK: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 85 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
    • TABLE 86 ITALY: KEY MACROINDICATORS
    • TABLE 87 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 88 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 89 ITALY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 90 ITALY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 91 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 92 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
    • TABLE 93 SPAIN: KEY MACROINDICATORS
    • TABLE 94 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 95 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 96 SPAIN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 97 SPAIN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 99 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 100 ROE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 101 ROE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 ROE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 103 ROE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 ROE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 105 ROE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 37 APAC: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS)
    • TABLE 106 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 107 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 109 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 111 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 113 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
    • TABLE 114 CHINA: KEY MACROINDICATORS
    • TABLE 115 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 116 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 CHINA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 118 CHINA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 120 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
    • TABLE 121 JAPAN: KEY MACROINDICATORS
    • TABLE 122 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 123 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 124 JAPAN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 125 JAPAN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 127 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
    • TABLE 128 INDIA: KEY MACROINDICATORS
    • TABLE 129 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 130 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 INDIA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 132 INDIA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 133 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 134 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF APAC
    • TABLE 135 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 136 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 137 ROAPAC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 138 ROAPAC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 139 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 140 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 141 ROW: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 142 ROW: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 143 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 144 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 145 ROW: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
    • TABLE 146 ROW: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES
  • 10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
    • FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE BREAST LESION LOCALIZATION MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 40 GLOBAL BREAST LESION LOCALIZATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 41 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION QUADRANT (2020)
  • 10.6 COMPANY EVALUATION QUADRANT FOR START-UPS
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 DYNAMIC COMPANIES
    • 10.6.3 STARTING BLOCKS
    • 10.6.4 RESPONSIVE COMPANIES
    • FIGURE 42 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
  • 10.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 147 PRODUCT PORTFOLIO ANALYSIS: BREAST LESION LOCALIZATION MARKET
  • 10.8 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE BREAST LESION LOCALIZATION MARKET
    • TABLE 148 GEOGRAPHIC REVENUE MIX: BREAST LESION LOCALIZATION MARKET (2020)
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 DEALS
    • TABLE 149 DEALS
    • 10.9.2 PRODUCT LAUNCHES AND UPGRADES
    • TABLE 150 PRODUCT LAUNCHES AND UPGRADES
  • 10.10 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
  • 10.11 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
  • 10.12 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION
  • 10.13 QUALITATIVE ASSESSMENT OF REPLACEMENT TRENDS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 HOLOGIC, INC.
    • TABLE 151 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 46 HOLOGIC, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.2 BECTON, DICKINSON AND COMPANY
    • TABLE 152 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.3 MERIT MEDICAL SYSTEMS
    • TABLE 153 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
    • FIGURE 48 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.4 LEICA BIOSYSTEMS NUSSLOCH GMBH
    • TABLE 154 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.5 ARGON MEDICAL DEVICES
    • TABLE 155 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
    • 11.1.6 LAURANE MEDICAL LLC
    • TABLE 156 LAURANE MEDICAL LLC: BUSINESS OVERVIEW
    • 11.1.7 ENDOMAGNETICS LTD. (ENDOMAG)
    • TABLE 157 ENDOMAGNETICS LIMITED: BUSINESS OVERVIEW
    • 11.1.8 INTRAMEDICAL IMAGING, LLC
    • TABLE 158 INTRAMEDICAL IMAGING, LLC: BUSINESS OVERVIEW
    • 11.1.9 ISOAID
    • TABLE 159 ISOAID: BUSINESS OVERVIEW
    • 11.1.10 SURGICEYE GMBH
    • TABLE 160 SURGICEYE GMBH: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 RANFAC CORP.
    • TABLE 161 RANFAC CORP.: BUSINESS OVERVIEW
    • 11.2.2 MERMAID MEDICAL GROUP
    • TABLE 162 MERMAID MEDICAL GROUP: BUSINESS OVERVIEW
    • 11.2.3 IZI MEDICALPRODUCTS, LLC
    • TABLE 163 IZI MEDICAL PRODUCTS, LLC: BUSINESS OVERVIEW
    • 11.2.4 MATEK MEDIKAL
    • TABLE 164 MATEK MEDIKAL: BUSINESS OVERVIEW
    • 11.2.5 TSUNAMI MEDICAL SRL
    • TABLE 165 TSUNAMI MEDICAL SRL: BUSINESS OVERVIEW
    • 11.2.6 BPB MEDICA
    • TABLE 166 BPB MEDICA: BUSINESS OVERVIEW
    • 11.2.7 SIRIUS MEDICAL SYSTEMS B.V.
    • TABLE 167 SIRIUS MEDICAL SYSTEMS B.V.: BUSINESS OVERVIEW
    • 11.2.8 MOLLI SURGICAL INC.
    • TABLE 168 MOLLI SURGICAL INC.: BUSINESS OVERVIEW
    • 11.2.9 STERYLAB S.R.L.
    • TABLE 169 STERYLAB S.R.L.: BUSINESS OVERVIEW
    • 11.2.10 CP MEDICAL
    • TABLE 170 CP MEDICAL: BUSINESS OVERVIEW
    • 11.2.11 MDL SRL
    • TABLE 171 MDL SRL: BUSINESS OVERVIEW
    • 11.2.12 BIOMEDICAL SRL
    • TABLE 172 BIOMEDICAL SRL: BUSINESS OVERVIEW
    • 11.2.13 ELUCENT MEDICAL
    • TABLE 173 ELUCENT MEDICAL: BUSINESS OVERVIEW
    • 11.2.14 VIGEO SRL
    • TABLE 174 VIGEO SRL: BUSINESS OVERVIEW
    • 11.2.15 MEDAX MEDICAL DEVICES
    • TABLE 175 MEDAX MEDICAL DEVICES: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 RELATED REPORTS
  • 12.4 AUTHOR DETAILS
Back to Top
전화 문의
F A Q